Cogniss
Cogniss is a UK/Australian no-code platform that enables clinicians, researchers, NHS organisations and life science companies to build, deploy and scale compliant patient-facing digital health apps across iOS, Android and web.
- Company typePrivate
- Founded2016
- HeadquartersCambridge, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingSoftware
What Cogniss does
Cogniss is a privately held UK and Australian software company that operates a no-code ecosystem purpose-built for building patient-facing digital health applications. Its platform consists of four modular products — Cogniss Creator (an advanced no-code app editor with 100+ pre-built, health-specific components), Cogniss Studio (a template-based simpler app creator), Cogniss Super App (a multi-app container for organisations), and Cogniss Insights (data dashboards supporting micro-randomized trials and research analytics) — and is built on a Certified AWS Well-Architected Framework. The platform is positioned for three primary customer segments: health systems and providers (including NHS Trusts, primary care networks and health innovation networks), academic and clinical researchers at universities, and life science companies gathering real-world evidence. The user base also includes clinicians, SMEs and workplace well-being buyers.
Cogniss generates revenue through a tiered annual subscription model — App Builder, App Builder Pro and Enterprise Builder — supplemented by Professional Services, an add-on DTAC 'SelfCert' compliance package, and a quote-based Consumer tier. Distribution runs through a hybrid GTM: enterprise field sales led by Managing Director Dr Lloyd Humphreys (UK) and Chief Marketing Officer Nivedita Dangwal (Australia), self-serve sign-up for individual creators, channel partnerships with AWS (ISV Accelerate / Public Sector) and ORCHA, and structured cohort programmes (Health Innovation East Digital Hub, Clinnovate WM, NHS Clinical Entrepreneur Programme, Ripple challenges) that act as land-and-expand pipelines. Apps built on Cogniss can be published as native iOS, Android and web applications, aggregated into curated portfolios via the wholly-owned Ripple Scale digital health publisher, and distributed through app stores and the ORCHA assessment network. The company maintains offices in Cambridge, UK (global HQ, established 2023) and Surry Hills, Sydney (Australia).
Cogniss firmographics
Firmographics- Name
- Cogniss
- Legal name
- Cogniss®
- Website
- https://cogniss.com
- Company type
- Private
- Founded year
- 2016
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Cogniss is a UK/Australian no-code platform that enables clinicians, researchers, NHS organisations and life science companies to build, deploy and scale compliant patient-facing digital health apps across iOS, Android and web.
- Ownership category
- akta.pro rank
Cogniss industry classification
Industry- Product category
- No-code digital health application development platform
- NAICS
- Software Publishers (513210)
- SIC
- Services-Prepackaged Software (7372)
- akta.pro primary industry
- Low-Code/No-Code Application Platforms (HDAEAKAA)
- akta.pro secondary industry
- Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways) (HLACAFAO)
Keywords
Where Cogniss is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
Cogniss business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Marketing or Sales, Operations
Revenue model
- Platform subscription (tiered SaaS): Tiered subscription plans (App Builder, App Builder Pro, Enterprise Builder) with usage caps on apps, app builders, and end users; paid annually with add-ons for extra builders, DTAC support and Professional Services. Consumer plan is quote-based.
- Freemium / free trial: Users can 'Get started for free and create a pilot app' before pitching their idea, with a free Academy, supporting land-and-expand into paid tiers.
- Enterprise licensing to health providers: Enterprises can 'sell direct or licence to health providers globally', and the platform positions itself as 'A single enterprise infrastructure for health providers' to deliver diverse solutions to patients and consumers.
- Professional services & programme partnerships: Professional Service packages available as add-ons, alongside structured innovation programmes (e.g., Clinnovate WM, Health Innovation East Digital Hub) where Cogniss is funded or co-funded by NHS/regional partners to run multi-cohort build-and-pilot engagements.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Subscription | Annual | App Builder — 1 unique app, 5 builders, up to 5,000 end users, native iOS/Android/Web launch |
| Subscription | Annual | App Builder Pro — 5 unique apps, 20 builders, up to 30,000 end users, multi-app Super App |
| Subscription | Multi-year contract | Enterprise Builder — UNLIMITED apps, UNLIMITED builders, up to 50,000 end users |
| Other | — | Consumer — quote-based, contact sales |
| Freemium | Pay-as-you-go | Free trial / freemium entry point |
Go-to-market motion5 records
Distribution channels5 records
Marketing channels9 records
Cogniss product offering
Product offeringCore offering
Cogniss provides a no-code platform that enables healthcare organizations, life sciences companies, academic researchers, and clinician-entrepreneurs to build patient-facing digital health apps without coding. The platform includes 100+ pre-built digital health components, built-in compliance tooling for GDPR, HIPAA, DTAC, and DiGA, and a Super App architecture that allows multiple apps to share infrastructure. Apps can be published natively to iOS, Android, and the web, with micro-randomized trial instrumentation for clinical research.
Product overview
Cogniss is a unified no-code platform-plus-modules ecosystem for building, deploying, and scaling digital health apps. The core platform consists of Cogniss Creator (the advanced no-code app editor with pre-built clinical and research features), Cogniss Studio (a simpler template-based no-code app creator), Cogniss Insights (the data and analytics dashboard for app users and study teams, supporting micro-randomized trials and data export via APIs), and Cogniss Super App (a single organizational app that hosts multiple sub-apps). Building on the platform, Cogniss publishes apps through its Ripple ecosystem — including the Ripple Women's Digital Health Challenge and Ripple Scale — and supports the community through Cogniss Academy, a learning platform for clinicians, researchers, and digital health builders.
Differentiator
Problem solved
Functional benefit
Brands
- Ripple Scale: The Digital Health Publisher - a Cogniss initiative that curates proven digital health apps into consolidated portfolios that health providers can adopt and deploy; launched in May 2026 and currently raising investment via Republic.
- Ripple
Products and services
- Cogniss Creator Advanced no-code app editor for designing and building complex digital health applications, used by enterprise and research teams.
- Cogniss Studio Template-based no-code app creator that allows non-developers to rapidly assemble digital health apps from pre-built components.
- Cogniss Insights Data dashboard and analytics layer that provides reporting, metrics, and API-based data access for apps built on Cogniss.
- Cogniss Super App Multi-app container architecture that allows a single host app to deliver many Cogniss-built digital health apps through shared infrastructure.
- Cogniss Academy Learning and certification platform that helps users master the Cogniss no-code platform through structured courses and training.
- Cogniss Ripple Digital health publishing programme through which cohort-based challenges (e.g., Ripple Women's Digital Health Challenge) are delivered to support the development of priority digital health apps.
- Ripple Scale Digital health publisher through which apps developed on Cogniss can be scaled and distributed at population level, acting as a publishing and distribution channel for qualifying apps.
Quantifiable outcome
- Up to 90% reduction in development time and total cost of ownership vs traditional development
- +5 more outcomes
Companies that use Cogniss
Customer profileNamed customers27 records
Segments6 records
Ideal customer profiles4 records
Cogniss technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- Yes
- API docs
- API detail
Core technology
AI maturity
App detail
Integration1 record
Feature8 records
Cogniss partnerships and signals
Strategic signalPartnerships
26 partnerships are on record, tiered flagship, core and minor.
- Amazon Web Services (AWS)flagshipAWS is the underlying cloud and infrastructure partner. Cogniss is built on a Certified AWS Well-Architected Framework, joined the AWS Public Sector Partner program in 2023, the AWS ISV Accelerate Program in 2024, and is a co-marketing partner on the Priority Digital Health Challenge 2025. AWS CMO Dr Rowland Illing sits on the challenge judging panel.
- Health Innovation EastflagshipStrategic partner running the Health Innovation East Digital Hub, a multi-cohort programme (Cohort 1 Oct 2024, Cohort 2 Feb 2025, Cohort 3 Oct 2025) that funds clinicians, academics and SMEs to build patient-facing apps on Cogniss. Programme was highly commended at the HTN Now Awards 2024/25 and is a 2026 HSJ Partnership Awards finalist with Cogniss.
- Health Innovation West MidlandsflagshipStrategic partner launching Clinnovate WM, a no-code innovation sandbox and structured six-month cohort programme (two cohorts/year, up to 10 clinicians each) for NHS clinical staff in the West Midlands. Builds on the Health Innovation East model. Announced December 2025 with first cohort launched February 2026.
- NHS Clinical Entrepreneur Programme (NHS CEP)corePartnered in February 2026 to give NHS Clinical Entrepreneurs access to the Cogniss platform and supporting programmes, including the Ripple Women's Digital Health Challenge. NHS CEP Fellows appear in Health Innovation East cohorts.
- Health Innovation Yorkshire & HumbercoreOriginal co-launch partner (with Health Innovation Network) of the Ripple Women's Digital Health Challenge in 2025; co-runs the programme that expanded from 2 to 26 women's health innovations.
- Health Innovation NetworkflagshipUmbrella network of 15 health innovation bodies across England. Original co-launch partner of the Ripple Women's Digital Health Challenge (2025) and parent body of Health Innovation East, Health Innovation West Midlands, and Health Innovation Yorkshire & Humber.
- ORCHAflagshipGlobal partnership (announced December 2022) under which apps built on Cogniss meet ORCHA's Baseline Review standards for data, security and accessibility, enabling distribution into NHS and other health system procurement channels. Joint launch event held at the Australian High Commission with Senator the Hon Don Farrell.
- The Sound DoctorcoreStrategic content partnership (announced July 2023) with UK-based, QISMET-accredited healthcare content provider covering long-term conditions (diabetes, hypertension, COPD, back pain, dementia, etc.). The Sound Doctor's films, animations and courses are made available to Cogniss app creators; ORCHA rating of 83%.
- West Midlands Health Tech Innovation Accelerator (WMHTIA) / University of BirminghamflagshipCogniss joined WMHTIA, a £14M Innovate UK / West Midlands Combined Authorities programme led by the University of Birmingham, as tech partner in 2023. Programme aims to drive £80M+ in private health-tech investment over 2-3 years.
- The Validitron (University of Melbourne)corePartner in the Priority Digital Health Challenge 2025 alongside AWS, providing The Validitron Sandbox for testing and evaluation of cohort apps.
- Australasian Institute of Digital Health (AIDH)coreProgramme partner on the Priority Digital Health Challenge 2025 (and co-host of MedInfo23 where Cogniss ran a masterclass). AIDH CEO Anja Nikolic sits on the challenge judging panel.
- Digital Health Cooperative Research Centre (DHCRC)coreProgramme partner on the Priority Digital Health Challenge 2025; DHCRC CEO Annette Schmiede is a judging panellist.
- Talking HealthTechminorProgramme partner on the Priority Digital Health Challenge 2025 and podcast distribution channel (multiple episodes feature Cogniss). Founder Peter Birch is a judging panellist.
- NEXTGENminorProgramme partner on the Priority Digital Health Challenge 2025.
- TechUKminorSupporting partner of the expanded Ripple Women's Digital Health Challenge (2026).
- AIRE InnovatecoreNew partnership announced June 2026 to help neighbourhood teams digitise care pathways in a day.
- Eastern AHSN (Academic Health Science Network)minorCo-hosted 'How to create an NHS-ready app' live masterclass and webinar series (2023) to teach healthcare experts about no-code for digital health.
- Imperial College London (IC Medathon)minorPartner of the Imperial College London IC Medathon (Feb 2023), a medical hackathon for medical students; Cogniss demonstrated how clinicians can use no-code to design health solutions. 85 participants created multiple MVP health apps.
- Queen Mary University of London (Barts and The London Innovation in Medicine Society)minorPlatform partner for the Barts and The London Digital Health Hackathon (March 2, 2025) at Queen Mary University of London. Cogniss enabled participants to build functional digital health apps in a single day.
- Westmead (Global Harvard Health Systems Hackathon)minorCogniss supported the 6th (2025) and 7th (2026) Global Harvard Health Systems Hackathon at Westmead, Australia, providing no-code platform access to early-stage innovators.
- Singapore (SGHackitRx 2025 / 34th Singapore Pharmacy Congress)minorPowered innovation at SGHackitRx 2025 during the 34th Singapore Pharmacy Congress (December 2025).
- World Health Organization Regional Office for Europe (WHO/Europe)flagshipCogniss presented and built an app live at the WHO Europe Second Symposium on the Future of Digital Health Systems in Porto, Portugal (2023); appointed Chair of the WHO/Europe Digital Innovation and AI working group in March 2026.
- Ripple Scale (Cogniss-owned digital health publisher)flagshipRipple Scale is powered by Cogniss and acts as a digital health publisher that curates apps into portfolios (mental health, women's health, children & young people) for one-contract, one-stack adoption by health systems. Currently raising investment via Republic.
- UK Department for Business and Trade (DBT) / Department for International Trade (DIT)coreUK government department that supported Cogniss in setting up its global HQ in Cambridge (2023) and in joining the UK Global Entrepreneur Program (GEP) in 2022; also featured Cogniss in the UK Government's Digital Health Playbook.
- Investment NSWminorAustralian state investment agency that supported Cogniss in establishing its global HQ in Cambridge, UK (2023).
- Austrade (Australian Trade and Investment Commission)minorAustralian government trade and investment body that supported Cogniss's UK expansion, including leveraging the Australia-UK Free Trade Agreement.
Scale indicators9 records
Recent moves9 records
Expansion highlights7 records
Cogniss competitors and assessment
Company assessmentMarket position
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Cogniss social profiles
Digital presenceCogniss compliance and trust
Trust signalCompliance5 records
Cogniss financial estimates
Financial estimateRevenue estimate
Valuation estimate
Cogniss leadership team
Management profileNumber of profiles
Profiles6 records
Cogniss subsidiaries and ownership
Company hierarchySubsidiaries1 record
Cogniss funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Cogniss M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Cogniss
What does Cogniss do?
Cogniss provides a no-code platform that enables healthcare organizations, life sciences companies, academic researchers, and clinician-entrepreneurs to build patient-facing digital health apps without coding. The platform includes 100+ pre-built digital health components, built-in compliance tooling for GDPR, HIPAA, DTAC, and DiGA, and a Super App architecture that allows multiple apps to share infrastructure. Apps can be published natively to iOS, Android, and the web, with micro-randomized trial instrumentation for clinical research.
Is Cogniss a public or private company?
Cogniss is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Cogniss founded?
Cogniss was founded in 2016. It employs 11 to 50 people.
Where is Cogniss based?
Cogniss is headquartered in Cambridge, United Kingdom, in the Europe region.
How does Cogniss make money?
Four revenue lines are on record. Platform subscription (tiered SaaS) is the primary driver. The others are freemium / free trial, enterprise licensing to health providers and professional services & programme partnerships.
Does Cogniss have an API?
Yes. Cogniss exposes API capabilities that allow apps built on the platform to (1) integrate with wearables to facilitate self-reporting of medication intake and monitoring of health markers, and (2) connect app data with external data visualization tools via APIs. Specific details on type (REST/GraphQL), authentication method, rate limits, versioning, and sandbox availability are not publicly disclosed. No public developer documentation URL is published on the site.
What industry is Cogniss in?
Cogniss's product category is No-code digital health application development platform. Its primary akta.pro industry code is HDAEAKAA, Low-Code/No-Code Application Platforms, with a secondary code of HLACAFAO, Data Aggregation, Interoperability & APIs for RPM (FHIR/IoMT Gateways). Its NAICS code is 513210 and its SIC code is 7372.